Acrivon Therapeutics, Inc. (ACRV) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$42.37M (1)

—

+$42.37M

9,366

0.0219%

$17.23K

—

Perceptive Advisors LLC entity

10% owner

$20.00M (1)

$3.76M (5)

+$16.24M

3,104,139

7.24%

$5.71M

+3.2%

Chione Ltd entity

10% owner

$5.00M (1)

$97.58K (5)

+$4.90M

3,848,632

8.98%

$7.08M

—

Peter Blume-Jensen

President and CEO

$82.12K (1)

$34.41K (3)

+$47.71K

2,615,911

6.10%

$4.81M

+125.0%

Eric Devroe

Chief Operating Officer

$17.22K (1)

$1.21K (1)

+$16.00K

146,349

0.3415%

$269.28K

+621.8%

Adam D. Levy

Chief Financial Officer

$15.00K (1)

$1.79K (1)

+$13.21K

66,008

0.1540%

$121.45K

+395.7%

Mary Miller

Chief Legal Officer

—

$2.91K (4)

−$2.91K

81,202

0.1895%

$149.41K

+100.9%

Erick Gamelin

Chief Development Officer

—

$804.00 (1)

−$804.00

52,592

0.1227%

$96.77K

—

Katharine Peterson

Chief Accounting Officer

—

$203.01 (1)

−$203.01

18,033

0.0421%

$33.18K

+273.2%

Kristina Masson

EVP - Business Operations

—

2,687,343

6.27%

$4.94M

+130.5%

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

888,130

2.07%

$1.63M

—

Mansoor Raza Mirza

Chief Medical Officer

—

38,817

0.0906%

$71.42K

—

Michaela Levin

Chief Business Officer

—

30,000

0.0700%

$55.20K

—

Rasmus Holm-Jorgensen

Chief Financial Officer

—

26,088

0.0609%

$48.00K

—

Derek DiRocco

Director

—

9,366

0.0219%

$17.23K

—

Santhosh Palani

Director

—

9,366

0.0219%

$17.23K

—

Ivana Magovcevic-Liebisch

Director

—

9,366

0.0219%

$17.23K

—

Michael John Tomsicek

Director

—

9,366

0.0219%

$17.23K

—

Sharon Shacham

Director

—

9,366

0.0219%

$17.23K

—

Charles M Baum

Director

—

9,366

0.0219%

$17.23K

—

Acrivon Therapeutics, Inc.

What the insiders did Net buying

By person